カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のソマトスタチン及びソマトスタチン類似体市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Somatostatin and Somatostatin Analogs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19637）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19637
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のソマトスタチン及びソマトスタチン類似体市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ソマトスタチン及びソマトスタチン類似体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のソマトスタチン及びソマトスタチン類似体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ソマトスタチン及びソマトスタチン類似体市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・オクトレオチド、ランレオチド、パシレオチド、その他

用途別セグメントは次のように区分されます。
・病院、薬局、その他

世界のソマトスタチン及びソマトスタチン類似体市場の主要な市場プレーヤーは以下のとおりです。
・Novartis、Pfizer、Ispen、HYBIO、TianTaiShan

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ソマトスタチン及びソマトスタチン類似体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なソマトスタチン及びソマトスタチン類似体メーカーの企業概要、2019年～2022年までのソマトスタチン及びソマトスタチン類似体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なソマトスタチン及びソマトスタチン類似体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ソマトスタチン及びソマトスタチン類似体の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのソマトスタチン及びソマトスタチン類似体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのソマトスタチン及びソマトスタチン類似体市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびソマトスタチン及びソマトスタチン類似体の産業チェーンを掲載しています。
・第13、14、15章では、ソマトスタチン及びソマトスタチン類似体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ソマトスタチン及びソマトスタチン類似体の概要
- 種類別分析（2017年vs2021年vs2028年）：オクトレオチド、ランレオチド、パシレオチド、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、薬局、その他
- 世界のソマトスタチン及びソマトスタチン類似体市場規模・予測
- 世界のソマトスタチン及びソマトスタチン類似体生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis、Pfizer、Ispen、HYBIO、TianTaiShan
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：オクトレオチド、ランレオチド、パシレオチド、その他
・用途別分析2017年-2028年：病院、薬局、その他
・ソマトスタチン及びソマトスタチン類似体の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ソマトスタチン及びソマトスタチン類似体のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ソマトスタチン及びソマトスタチン類似体のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ソマトスタチン及びソマトスタチン類似体の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ソマトスタチン及びソマトスタチン類似体の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Somatostatin and Somatostatin Analogs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Somatostatin and Somatostatin Analogs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Somatostatin and Somatostatin Analogs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Octreotide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Somatostatin and Somatostatin Analogs include Novartis, Pfizer, Ispen, HYBIO, and TianTaiShan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Somatostatin and Somatostatin Analogs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Octreotide
Lanreotide
Pasireotide
Other
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Somatostatin and Somatostatin Analogs market are listed below:
Novartis
Pfizer
Ispen
HYBIO
TianTaiShan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin and Somatostatin Analogs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Somatostatin and Somatostatin Analogs, with price, sales, revenue and global market share of Somatostatin and Somatostatin Analogs from 2019 to 2022.
Chapter 3, the Somatostatin and Somatostatin Analogs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin and Somatostatin Analogs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Somatostatin and Somatostatin Analogs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Somatostatin and Somatostatin Analogs.
Chapter 13, 14, and 15, to describe Somatostatin and Somatostatin Analogs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Somatostatin and Somatostatin Analogs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Somatostatin and Somatostatin Analogs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Octreotide
1.2.3 Lanreotide
1.2.4 Pasireotide
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Somatostatin and Somatostatin Analogs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Somatostatin and Somatostatin Analogs Market Size & Forecast
1.4.1 Global Somatostatin and Somatostatin Analogs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Somatostatin and Somatostatin Analogs Sales in Volume (2017-2028)
1.4.3 Global Somatostatin and Somatostatin Analogs Price (2017-2028)
1.5 Global Somatostatin and Somatostatin Analogs Production Capacity Analysis
1.5.1 Global Somatostatin and Somatostatin Analogs Total Production Capacity (2017-2028)
1.5.2 Global Somatostatin and Somatostatin Analogs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Somatostatin and Somatostatin Analogs Market Drivers
1.6.2 Somatostatin and Somatostatin Analogs Market Restraints
1.6.3 Somatostatin and Somatostatin Analogs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Somatostatin and Somatostatin Analogs Product and Services
2.1.4 Novartis Somatostatin and Somatostatin Analogs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Somatostatin and Somatostatin Analogs Product and Services
2.2.4 Pfizer Somatostatin and Somatostatin Analogs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ispen
2.3.1 Ispen Details
2.3.2 Ispen Major Business
2.3.3 Ispen Somatostatin and Somatostatin Analogs Product and Services
2.3.4 Ispen Somatostatin and Somatostatin Analogs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 HYBIO
2.4.1 HYBIO Details
2.4.2 HYBIO Major Business
2.4.3 HYBIO Somatostatin and Somatostatin Analogs Product and Services
2.4.4 HYBIO Somatostatin and Somatostatin Analogs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 TianTaiShan
2.5.1 TianTaiShan Details
2.5.2 TianTaiShan Major Business
2.5.3 TianTaiShan Somatostatin and Somatostatin Analogs Product and Services
2.5.4 TianTaiShan Somatostatin and Somatostatin Analogs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Somatostatin and Somatostatin Analogs Breakdown Data by Manufacturer
3.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Somatostatin and Somatostatin Analogs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Somatostatin and Somatostatin Analogs
3.4 Market Concentration Rate
3.4.1 Top 3 Somatostatin and Somatostatin Analogs Manufacturer Market Share in 2021
3.4.2 Top 6 Somatostatin and Somatostatin Analogs Manufacturer Market Share in 2021
3.5 Global Somatostatin and Somatostatin Analogs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Somatostatin and Somatostatin Analogs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Somatostatin and Somatostatin Analogs Market Size by Region
4.1.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Region (2017-2028)
4.1.2 Global Somatostatin and Somatostatin Analogs Revenue by Region (2017-2028)
4.2 North America Somatostatin and Somatostatin Analogs Revenue (2017-2028)
4.3 Europe Somatostatin and Somatostatin Analogs Revenue (2017-2028)
4.4 Asia-Pacific Somatostatin and Somatostatin Analogs Revenue (2017-2028)
4.5 South America Somatostatin and Somatostatin Analogs Revenue (2017-2028)
4.6 Middle East and Africa Somatostatin and Somatostatin Analogs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Type (2017-2028)
5.2 Global Somatostatin and Somatostatin Analogs Revenue by Type (2017-2028)
5.3 Global Somatostatin and Somatostatin Analogs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Somatostatin and Somatostatin Analogs Sales in Volume by Application (2017-2028)
6.2 Global Somatostatin and Somatostatin Analogs Revenue by Application (2017-2028)
6.3 Global Somatostatin and Somatostatin Analogs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Somatostatin and Somatostatin Analogs Sales by Type (2017-2028)
7.2 North America Somatostatin and Somatostatin Analogs Sales by Application (2017-2028)
7.3 North America Somatostatin and Somatostatin Analogs Market Size by Country
7.3.1 North America Somatostatin and Somatostatin Analogs Sales in Volume by Country (2017-2028)
7.3.2 North America Somatostatin and Somatostatin Analogs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Somatostatin and Somatostatin Analogs Sales by Type (2017-2028)
8.2 Europe Somatostatin and Somatostatin Analogs Sales by Application (2017-2028)
8.3 Europe Somatostatin and Somatostatin Analogs Market Size by Country
8.3.1 Europe Somatostatin and Somatostatin Analogs Sales in Volume by Country (2017-2028)
8.3.2 Europe Somatostatin and Somatostatin Analogs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Type (2017-2028)
9.2 Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Application (2017-2028)
9.3 Asia-Pacific Somatostatin and Somatostatin Analogs Market Size by Region
9.3.1 Asia-Pacific Somatostatin and Somatostatin Analogs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Somatostatin and Somatostatin Analogs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Somatostatin and Somatostatin Analogs Sales by Type (2017-2028)
10.2 South America Somatostatin and Somatostatin Analogs Sales by Application (2017-2028)
10.3 South America Somatostatin and Somatostatin Analogs Market Size by Country
10.3.1 South America Somatostatin and Somatostatin Analogs Sales in Volume by Country (2017-2028)
10.3.2 South America Somatostatin and Somatostatin Analogs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Type (2017-2028)
11.2 Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Application (2017-2028)
11.3 Middle East & Africa Somatostatin and Somatostatin Analogs Market Size by Country
11.3.1 Middle East & Africa Somatostatin and Somatostatin Analogs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Somatostatin and Somatostatin Analogs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Somatostatin and Somatostatin Analogs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Somatostatin and Somatostatin Analogs
12.3 Somatostatin and Somatostatin Analogs Production Process
12.4 Somatostatin and Somatostatin Analogs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Somatostatin and Somatostatin Analogs Typical Distributors
13.3 Somatostatin and Somatostatin Analogs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Somatostatin and Somatostatin Analogs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Somatostatin and Somatostatin Analogs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Somatostatin and Somatostatin Analogs Product and Services
Table 6. Novartis Somatostatin and Somatostatin Analogs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Somatostatin and Somatostatin Analogs Product and Services
Table 10. Pfizer Somatostatin and Somatostatin Analogs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ispen Basic Information, Manufacturing Base and Competitors
Table 12. Ispen Major Business
Table 13. Ispen Somatostatin and Somatostatin Analogs Product and Services
Table 14. Ispen Somatostatin and Somatostatin Analogs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. HYBIO Basic Information, Manufacturing Base and Competitors
Table 16. HYBIO Major Business
Table 17. HYBIO Somatostatin and Somatostatin Analogs Product and Services
Table 18. HYBIO Somatostatin and Somatostatin Analogs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. TianTaiShan Basic Information, Manufacturing Base and Competitors
Table 20. TianTaiShan Major Business
Table 21. TianTaiShan Somatostatin and Somatostatin Analogs Product and Services
Table 22. TianTaiShan Somatostatin and Somatostatin Analogs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Somatostatin and Somatostatin Analogs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Somatostatin and Somatostatin Analogs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Somatostatin and Somatostatin Analogs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Somatostatin and Somatostatin Analogs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Somatostatin and Somatostatin Analogs Production Site of Key Manufacturer
Table 28. Somatostatin and Somatostatin Analogs New Entrant and Capacity Expansion Plans
Table 29. Somatostatin and Somatostatin Analogs Mergers & Acquisitions in the Past Five Years
Table 30. Global Somatostatin and Somatostatin Analogs Sales by Region (2017-2022) & (K Units)
Table 31. Global Somatostatin and Somatostatin Analogs Sales by Region (2023-2028) & (K Units)
Table 32. Global Somatostatin and Somatostatin Analogs Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Somatostatin and Somatostatin Analogs Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 35. Global Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 36. Global Somatostatin and Somatostatin Analogs Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Somatostatin and Somatostatin Analogs Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Somatostatin and Somatostatin Analogs Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Somatostatin and Somatostatin Analogs Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 41. Global Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 42. Global Somatostatin and Somatostatin Analogs Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Somatostatin and Somatostatin Analogs Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Somatostatin and Somatostatin Analogs Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Somatostatin and Somatostatin Analogs Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Somatostatin and Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
Table 47. North America Somatostatin and Somatostatin Analogs Sales by Country (2023-2028) & (K Units)
Table 48. North America Somatostatin and Somatostatin Analogs Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Somatostatin and Somatostatin Analogs Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 51. North America Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 52. North America Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 53. North America Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 54. Europe Somatostatin and Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
Table 55. Europe Somatostatin and Somatostatin Analogs Sales by Country (2023-2028) & (K Units)
Table 56. Europe Somatostatin and Somatostatin Analogs Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Somatostatin and Somatostatin Analogs Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 61. Europe Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Somatostatin and Somatostatin Analogs Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Somatostatin and Somatostatin Analogs Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 70. South America Somatostatin and Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
Table 71. South America Somatostatin and Somatostatin Analogs Sales by Country (2023-2028) & (K Units)
Table 72. South America Somatostatin and Somatostatin Analogs Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Somatostatin and Somatostatin Analogs Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 75. South America Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 76. South America Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 77. South America Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Somatostatin and Somatostatin Analogs Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Somatostatin and Somatostatin Analogs Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Somatostatin and Somatostatin Analogs Sales by Application (2023-2028) & (K Units)
Table 86. Somatostatin and Somatostatin Analogs Raw Material
Table 87. Key Manufacturers of Somatostatin and Somatostatin Analogs Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Somatostatin and Somatostatin Analogs Typical Distributors
Table 91. Somatostatin and Somatostatin Analogs Typical Customers
List of Figures
Figure 1. Somatostatin and Somatostatin Analogs Picture
Figure 2. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Type in 2021
Figure 3. Octreotide
Figure 4. Lanreotide
Figure 5. Pasireotide
Figure 6. Other
Figure 7. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Somatostatin and Somatostatin Analogs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Somatostatin and Somatostatin Analogs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Somatostatin and Somatostatin Analogs Sales (2017-2028) & (K Units)
Figure 14. Global Somatostatin and Somatostatin Analogs Price (2017-2028) & (USD/Unit)
Figure 15. Global Somatostatin and Somatostatin Analogs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Somatostatin and Somatostatin Analogs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Somatostatin and Somatostatin Analogs Market Drivers
Figure 18. Somatostatin and Somatostatin Analogs Market Restraints
Figure 19. Somatostatin and Somatostatin Analogs Market Trends
Figure 20. Global Somatostatin and Somatostatin Analogs Sales Market Share by Manufacturer in 2021
Figure 21. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Manufacturer in 2021
Figure 22. Somatostatin and Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Somatostatin and Somatostatin Analogs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Somatostatin and Somatostatin Analogs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Somatostatin and Somatostatin Analogs Sales Market Share by Region (2017-2028)
Figure 26. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Region (2017-2028)
Figure 27. North America Somatostatin and Somatostatin Analogs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Somatostatin and Somatostatin Analogs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Somatostatin and Somatostatin Analogs Revenue (2017-2028) & (USD Million)
Figure 30. South America Somatostatin and Somatostatin Analogs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Somatostatin and Somatostatin Analogs Revenue (2017-2028) & (USD Million)
Figure 32. Global Somatostatin and Somatostatin Analogs Sales Market Share by Type (2017-2028)
Figure 33. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Type (2017-2028)
Figure 34. Global Somatostatin and Somatostatin Analogs Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 36. Global Somatostatin and Somatostatin Analogs Revenue Market Share by Application (2017-2028)
Figure 37. Global Somatostatin and Somatostatin Analogs Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Somatostatin and Somatostatin Analogs Sales Market Share by Type (2017-2028)
Figure 39. North America Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 40. North America Somatostatin and Somatostatin Analogs Sales Market Share by Country (2017-2028)
Figure 41. North America Somatostatin and Somatostatin Analogs Revenue Market Share by Country (2017-2028)
Figure 42. United States Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Type (2017-2028)
Figure 46. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 47. Europe Somatostatin and Somatostatin Analogs Sales Market Share by Country (2017-2028)
Figure 48. Europe Somatostatin and Somatostatin Analogs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Somatostatin and Somatostatin Analogs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Somatostatin and Somatostatin Analogs Revenue Market Share by Region (2017-2028)
Figure 58. China Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Somatostatin and Somatostatin Analogs Sales Market Share by Type (2017-2028)
Figure 65. South America Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 66. South America Somatostatin and Somatostatin Analogs Sales Market Share by Country (2017-2028)
Figure 67. South America Somatostatin and Somatostatin Analogs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Somatostatin and Somatostatin Analogs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Somatostatin and Somatostatin Analogs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Somatostatin and Somatostatin Analogs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Somatostatin and Somatostatin Analogs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Somatostatin and Somatostatin Analogs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Somatostatin and Somatostatin Analogs in 2021
Figure 79. Manufacturing Process Analysis of Somatostatin and Somatostatin Analogs
Figure 80. Somatostatin and Somatostatin Analogs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のソマトスタチン薬市場2022年：市場規模予測（～2028年）
  • 世界の酢酸ソマトスタチン市場2022年：市場規模予測（～2028年）
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 世界のハイブリッド手首固定器市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19637 )"世界のソマトスタチン及びソマトスタチン類似体市場2022年：市場規模予測（～2028年）" (英文：Global Somatostatin and Somatostatin Analogs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。